The impact of antibiotic resistance on hospitalized patients with Enterobacteriaceae (ENT) urinary tract infections (UTI): A multicenter analysis Posted on April 25, 2018 at 2:53 pm.Written by Spero Therapeutics View Presentation Post navigation Understanding the SAR Interplay for Kidney Exposure and Cytotoxicity Facilitates the Design of Improved Polymyxin Derivatives – Identification of SPR206 as a Development CandidatePharmacokinetics and Pharmacodynamics of Tebipenem for Multi-Drug Resistant Enterobacteriaceae
